Robert James
Direktor/Vorstandsmitglied bei NeoPhore Ltd.
Profil
Robert I.
James is currently the Director at NeoPhore Ltd.
and the Managing Partner at Sixth Element Capital LLP.
Previously, he held positions as a Non-Executive Director at De Novo Pharmaceuticals Ltd., Oxford Immunotec Ltd., Sciona, Inc., and Prelude Ventures Ltd.
He also served as a Partner at Molten Ventures (Private Equity) from 2006 to 2010 and worked at Prelude Trust Plc from 2004 to 2009.
Dr. James obtained his undergraduate and doctorate degrees from the University of London.
Aktive Positionen von Robert James
Unternehmen | Position | Beginn |
---|---|---|
Sixth Element Capital LLP
Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital LLP is a venture capital firm headquartered in the UK. The firm founded in 2011 by Ralph Villiger. | Private Equity Investor | 27.11.2014 |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert James
Unternehmen | Position | Ende |
---|---|---|
Molten Ventures (Private Equity)
Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.09.2010 |
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Direktor/Vorstandsmitglied | 25.01.2010 |
Prelude Ventures Ltd.
Prelude Ventures Ltd. Investment ManagersFinance Prelude Ventures Ltd. used to provide investment services for startup companies. Its main targets were advanced materials, communications, drug discovery, medical devices and semiconductor sectors. The company was founded in 1984 and was located in Cambridge, UK. | Direktor/Vorstandsmitglied | 01.06.2006 |
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert James
University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Sciona, Inc. provides health and nutrition recommendations. It researches and develops DNA screens for common gene variants that affect an individual's response to food, medications and the environment. These genetic screens serve as the basis for providing personalized advice to consumers. The company was founded by Rosalynn Gill-Garrison and Gareth Roberts on June 8, 2000 and is headquartered in Boulder, CO. | Health Technology |
Prelude Ventures Ltd.
Prelude Ventures Ltd. Investment ManagersFinance Prelude Ventures Ltd. used to provide investment services for startup companies. Its main targets were advanced materials, communications, drug discovery, medical devices and semiconductor sectors. The company was founded in 1984 and was located in Cambridge, UK. | Finance |
Molten Ventures (Private Equity)
Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Finance |
Sixth Element Capital LLP
Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital LLP is a venture capital firm headquartered in the UK. The firm founded in 2011 by Ralph Villiger. | Finance |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Commercial Services |